FDA Holding Meeting to Discuss Safety of Breast Implants
The FDA Medical Devices Advisory Committee’s General and Plastic Surgery Devices Panel has announced plans to meet and discuss the risks and benefits of breast implants. Some women have reported suffering pain, fatigue, and other health problems in reaction to implants.
During the meeting, the panel will hear from patients, physicians, and industry representatives. Last month, the FDA issued warning letters to two breast implant manufacturers for not meeting the requirements in regards to long-term studies for safety and risks of their silicone gel-filled implants.
According to the FDA, there have been reports linking implants to a rare cancer called Ana-plastic Large Cell Lymphoma. 20% of women who receive implants have them removed within 8-10 years due to complications.